Reaction
Blast Cell Count Increased reporting signals
As of the last recalculation, Blast Cell Count Increased appears in 1,037 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 246.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 114 | 246.3 | 249.0 |
| Azacitidine | 190 | 157.1 | 158.2 |
| Azacitidine For | 76 | 90.4 | 90.8 |
| Hydroxyurea | 56 | 56.1 | 56.3 |
| Venetoclax | 137 | 51.3 | 51.4 |
| Deferasirox | 47 | 37.2 | 37.3 |
| Micafungin Sodium | 12 | 28.7 | 28.8 |
| Ruxolitinib | 87 | 26.5 | 26.5 |
| Imatinib | 20 | 23.2 | 23.2 |
| Romiplostim | 16 | 21.6 | 21.7 |
| Granisetron Hydrochloride | 11 | 21.4 | 21.4 |
| Posaconazole | 16 | 20.1 | 20.1 |
| Nilotinib | 26 | 18.1 | 18.1 |
| Granisetron | 9 | 17.4 | 17.4 |
| Itraconazole | 10 | 17.3 | 17.4 |
| Cytarabine | 47 | 16.4 | 16.4 |
| Posaconazole Delayed-Release | 8 | 14.7 | 14.7 |
| Imatinib Mesylate | 19 | 13.9 | 13.9 |
| Cefepime Hydrochloride | 11 | 13.8 | 13.8 |
| Voriconazole | 20 | 13.5 | 13.5 |
| Febuxostat Tablets 40 Mg | 6 | 11.9 | 11.9 |
| Febuxostat Tablets 80 Mg | 6 | 11.9 | 11.9 |
| Cefepime | 8 | 11.3 | 11.3 |
| Meropenem | 17 | 10.8 | 10.8 |
| Dasatinib | 19 | 10.4 | 10.4 |
| Paliperidone | 11 | 9.6 | 9.6 |
| Bosutinib | 4 | 9.0 | 9.0 |
| Olaparib | 7 | 6.8 | 6.8 |
| Eltrombopag Olamine | 7 | 6.1 | 6.1 |
| Paliperidone Palmitate | 9 | 5.7 | 5.7 |
| Pegfilgrastim | 15 | 3.1 | 3.1 |